好爽又高潮了毛片免费下载,国产97在线 | 亚洲,亚洲一区二区三区AV无码,特级AAAAAAAAA毛片免费视频

行業產品

  • 行業產品

上海泛柯實業有限公司


當前位置:上海泛柯實業有限公司>>抗體>>一抗>>FITC標記的腺嘌呤核苷酸轉運蛋白1抗體

FITC標記的腺嘌呤核苷酸轉運蛋白1抗體

返回列表頁
參  考  價面議
具體成交價以合同協議為準

產品型號

品       牌

廠商性質經銷商

所  在  地上海

聯系方式:馬經理查看聯系方式

更新時間:2015-05-08 10:48:34瀏覽次數:605次

聯系我時,請告知來自 智慧城市網

經營模式:經銷商

商鋪產品:9811條

所在地區:上海上海

聯系人:馬經理 (銷售專員)

產品簡介

FITC標記的腺嘌呤核苷酸轉運蛋白1抗體產品介紹:This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

詳細介紹

英文名稱Anti-ANT-1/FITC
中文名稱FITC標記的腺嘌呤核苷酸轉運蛋白1抗體
別    名heart/skeletal muscle isoform T1; Adenine nucleotide translocator 1 (skeletal muscle); Adenine nucleotide translocator 1; ADP; ADP ATP carrier protein 1; ADP ATP carrier protein heart/skeletal muscle isoform T1; ADP/ATP translocase 1; ADT1_HUMAN; ANT 1; ANT; ANT1; ATP carrier protein 1; ATP carrier protein; MSA02; PEO2; PEO3; SLC25A4; Solute carrier family 25 member 4; T1 antibody.
說 明 書100ul  
研究領域細胞生物  免疫學  神經生物學  信號轉導  細胞凋亡  細胞類型標志物  G蛋白信號  
抗體來源Rabbit
克隆類型Polyclonal
交叉反應Human, Mouse, Rat, Dog, Pig, Cow, Rabbit, Sheep, 
產品應用IF=1:50-200  
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量33kDa
細胞定位細胞膜 
性    狀Lyophilized or Liquid
濃    度1mg/ml
免 疫 原KLH conjugated synthetic peptide derived from human ATP carrier protein 1/Adenine Nucleotide Translocase 1
亞    型IgG
純化方法affinity purified by Protein A
儲 存 液Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
保存條件Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
產品介紹background:
Defects in SLC25A4 are a cause of progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 2 (PEOA2) [MIM:609283]. Progressive external ophthalmoplegia is characterized by progressive weakness of ocular muscles and levator muscle of the upper eyelid. In a minority of cases, it is associated with skeletal myopathy, which predominantly involves axial or proximal muscles and which causes abnormal fatigability and even permanent muscle weakness. Ragged-red fibers and atrophy are found on muscle biopsy. A large proportion of chronic ophthalmoplegias are associated with other symptoms, leading to a multisystemic pattern of this disease. Additional symptoms are variable, and may include cataracts, hearing loss, sensory axonal neuropathy, ataxia, depression, hypogonadism, and parkinsonism.

Subunit:
Found in a complex with ARL2, ARL2BP and SLC25A4. Interacts with ARL2BP (By similarity). Homodimer. Interacts with HIV-1 Vpr.

Subcellular Location:
Mitochondrion inner membrane; Multi-pass membrane protein.

DISEASE:
Defects in SLC25A4 are a cause of progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 2 (PEOA2) [MIM:609283]. Progressive external ophthalmoplegia is characterized by progressive weakness of ocular muscles and levator muscle of the upper eyelid. In a minority of cases, it is associated with skeletal myopathy, which predominantly involves axial or proximal muscles and which causes abnormal fatigability and even permanent muscle weakness. Ragged-red fibers and atrophy are found on muscle biopsy. A large proportion of chronic ophthalmoplegias are associated with other symptoms, leading to a multisystemic pattern of this disease. Additional symptoms are variable, and may include cataracts, hearing loss, sensory axonal neuropathy, ataxia, depression, hypogonadism, and parkinsonism.

Similarity:
Belongs to the mitochondrial carrier family. 
Contains 3 Solcar repeats.


感興趣的產品PRODUCTS YOU ARE INTERESTED IN

智慧城市網 設計制作,未經允許翻錄必究 .? ? ? Copyright(C)?2021 http://www.cmr6829.com,All rights reserved.

以上信息由企業自行提供,信息內容的真實性、準確性和合法性由相關企業負責,智慧城市網對此不承擔任何保證責任。 溫馨提示:為規避購買風險,建議您在購買產品前務必確認供應商資質及產品質量。

會員登錄

×

請輸入賬號

請輸入密碼

=

請輸驗證碼

收藏該商鋪

登錄 后再收藏

提示

您的留言已提交成功!我們將在第一時間回復您~